biosimilars in oncology: future directions
Published 4 years ago • 31 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
6:01
economic impact of biosimilars in oncology
-
7:20
biosimilars in oncology: addressing awareness
-
7:40
market-access considerations for biosimilars in oncology
-
2:32
switching to available biosimilars in oncology
-
4:12
the basics of biosimilars
-
9:26
the future direction of biosimilars
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
2:51:28
increasing the efficiency of biosimilar development programs (day 2)
-
8:07
biosimilars | what is a biosimilar? | gastrointestinal society
-
9:50
the role of pharmacodynamic biomarkers in biosimilar drug development
-
7:21
biologic drugs and biosimilars
-
38:15
biosimilars and biologics
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
5:20
data requirements for biosimilars
-
57:41
webinar: biologics & biosimilars
-
2:17
the future of us biosimilars
-
8:51
the approval process for biosimilars
-
16:47
what is needed and what is the role of biosimilars?
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
20:06
biologics and biosimilars: extrapolation of indications – information for healthcare providers